Harmony Biosciences Holdings Inc – Jahresabschlüsse (NASDAQ:HRMY) | MetaTrader

Vollständige Grafik anzeigen

Nachrichten

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Corcept's Q4 Earnings and Revenues Fall Short of Estimates

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

Früherer Generika-Start für Wakix: UBS senkt Kursziel für Harmony Biosciences

UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry

Truist bestätigt "Halten"-Rating für Harmony Biosciences mit Kursziel von 25 US-Dollar

Truist reiterates Hold on Harmony Biosciences stock, sets $25 target

AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales